WEGE3.SA (WEGE3.SA)

$205.0B
Market Cap
32.1
P/E Ratio
0.07
Beta
0.84%
Dividend Yield
Piotroski 6/9Altman Z 7.0 SafeROIC−WACC +18.1%

Quantitative Summary

Deterministic

Financial health is average: Piotroski 6/9, Altman Z 7.0.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The capital allocation efficiency of WEGE3.SA demonstrates robust fundamental quality, anchored by a significant 18.1% spread between its 26.0% ROIC and 8.0% cost of capital, indicating strong value creation potential relative to financing costs. This return profile is primarily driven by operational leverage rather than financial engineering or margin expansion alone; while the firm maintains healthy profitability with net margins at 15.6%, the DuPont decomposition suggests that high gross margins of 33.5% are being leveraged effectively, though revenue growth remains moderate at 7.4%. Solvency and earnings stability appear secure given a Piotroski F-Score of 6/9 and an Altman Z-Score of 7.0, positioning the entity in a low-risk zone regarding bankruptcy probability while exhibiting solid financial strength relative to typical industry peers.

Valuation metrics present a divergence between current market pricing and intrinsic value models derived from discounted cash flow analysis. The stock trades at a forward P/E multiple of 32.1x, which implies significant growth expectations are already embedded in the share price; however, this premium appears elevated when contrasted against a DCF-derived fair value estimate of $47. Unless implied future growth rates exceed those required to justify the current multiple relative to the calculated intrinsic value, the market may be pricing in an aggressive expansion trajectory that has not yet been realized by the 7.4% year-over-year revenue increase observed recently.

No specific data regarding risk factor deltas, insider trading activity, or Fama-French alpha performance was provided for this analysis; consequently, a detailed assessment of idiosyncratic risks versus systematic market exposure cannot be synthesized from the available inputs. The investment case rests entirely on whether the company can accelerate revenue growth to align with its high ROIC capabilities and validate the premium valuation against the $47 fair value benchmark without relying solely on margin expansion or leverage increases.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%8%10%
2%$61$40$30
3%$79$47$33
4%$115$57$37

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=8.0%, terminal growth 3%. Fair value $47 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

6/9
Piotroski F-Score
Average — mixed operational signals
7.0
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.

Profitability & Value Creation

33.5%
Gross Margin
15.6%
Net Margin
26.0%
ROIC
8.0%
WACC
ROIC − WACC Spread: +18.1%— Positive value creation spread.
+7.4%
Revenue Growth (YoY)
+5.5%
Earnings Growth (YoY)
3.8B
Free Cash Flow
143%
FCF Payout Ratio

⚠️ Dividend consumes >80% of FCF — sustainability risk.

Balance Sheet Health

1.30x
Debt / Equity
1.55x
Current Ratio
46.4x
Interest Coverage
-0.6x
Net Debt / EBITDA
1.88%
FCF Yield
9.3B
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $0.39
Act: $0.37
-5.4%
Q3
✗ Miss
Est: $0.41
Act: $0.38
-8.3%
Q2
✓ Beat
Est: $0.39
Act: $0.39
+1.7%
Q1
✗ Miss
Est: $0.38
Act: $0.38
-0.9%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

24.9
Forward P/E
PEG Ratio
11.77
Price/Book
7M
Avg Volume
$54.53
52W High
$35.25
52W Low
52W Range Position

ETF Contagion Visualizer

Simulate a price drop in WEGE3.SA to visualize passive redemption contagion across ETFs and collateral stocks.

WEGE3.SA Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
WEGE3.SAEpicenterEWZETFVALE3.SALow RiskNUHigh RiskITUB4UnknownPETR4UnknownPETR3.SALow Risk
WEGE3.SA Price Drop (%)0

If WEGE3.SA (WEGE3.SA) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Vale SA (VALE3.SA) as the most exposed collateral stock, sharing 1 ETFs with WEGE3.SA. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 1 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

WEGE3.SA Ownership Dynamics

Ticker
WEGE3.SA

ETFs with Highest WEGE3.SA Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

WEGE3.SA Capital Efficiency

How efficiently does WEGE3.SA convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$3.8B
EBITDA
$9.3B
FCF Conversion
40%
Reinvestment Rate
60%
40% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
26.0%
ROIC − WACC Spread
18.1%

WEGE3.SA converts 40% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 60% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 18.1% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare WEGE3.SA to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.